Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Open in API
Filings indexed 4,405 across all filing types
Latest filing 2025-09-26 Foreign Filer Report
Country FR France
Listing PA SAN

About Sanofi

https://www.sanofi.com/en/directory/

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2025-09-26 English
Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé num
Capital/Financing Update Classification · 95% confidence The document is a press release from Sanofi announcing an additional $625 million investment into its venture capital arm, 'Sanofi Ventures'. It details the strategic purpose of this capital allocation, the fund's focus areas, and quotes from the CEO and the head of Sanofi Ventures. This document describes a corporate financing and capital allocation activity rather than a periodic financial report, audit, or regulatory filing. It fits the definition of a 'Capital/Financing Update' (CAP) as it pertains to the company's capital structure and investment strategy.
2025-09-24 French
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a $625 million capital commitment to Sanofi Ventures. This relates to corporate financing and capital allocation strategy. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate fit as it covers updates on company fundraising and financing activities.
2025-09-24 English
Communiqué de presse : Mise en ligne du document "Q3 2025 Aide mémoire"
Report Publication Announcement Classification · 100% confidence The document is a press release from Sanofi announcing the publication of a 'Q3 2025 Aide mémoire' (a supplementary financial modeling document) on their investor website. It does not contain the actual financial results, but rather serves as a notification that the document is available online. Following the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-09-24 French
Press release: Availability of the Q3 2025 Aide mémoire
Report Publication Announcement Classification · 100% confidence The document is a press release announcing the availability of a 'Q3 2025 Aide mémoire' on the company's website. It does not contain the actual financial results or the report itself, but rather informs investors where to find the document for financial modeling purposes. Following the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-09-24 English
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
Regulatory Filings Classification · 95% confidence The document is a press release issued by Sanofi announcing that the FDA has granted 'fast track designation' to one of their investigational gene therapies (SAR446268). This is a corporate announcement regarding regulatory progress for a product candidate. Since it does not fit into specific categories like financial reports, board changes, or shareholder voting, it falls under the 'Regulatory Filings' (RNS) category as a general corporate regulatory announcement.
2025-09-23 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.